IP vs LYRA · P/E 43, $26.62B cap vs rev $1.5M
International Paper (IP) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the IP and LYRA stock pages for the full models.
Not investment advice.